Boog C - Search Results

1

Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers.

Hamidi A, Boog C, Jadhav S, Kreeftenberg H. Hamidi A, et al. Among authors: boog c. Vaccine. 2014 Jul 16;32(33):4124-30. doi: 10.1016/j.vaccine.2014.05.023. Epub 2014 Jun 9. Vaccine. 2014. PMID: 24923635 Review.

2

Vaccinology capacity building in Europe for innovative platforms serving emerging markets.

Hendriks J, Holleman M, Hamidi A, Beurret M, Boog C. Hendriks J, et al. Among authors: boog c. Hum Vaccin Immunother. 2013 Apr;9(4):932-6. doi: 10.4161/hv.23163. Epub 2013 Apr 1. Hum Vaccin Immunother. 2013. PMID: 23563518 Free PMC article.

3

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA. Verdijk P, et al. Among authors: boog cj. Vaccine. 2013 Nov 12;31(47):5531-6. doi: 10.1016/j.vaccine.2013.09.021. Epub 2013 Sep 21. Vaccine. 2013. PMID: 24063976 Clinical Trial.

4

Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.

Rots NY, Wijmenga-Monsuur AJ, Luytjes W, Kaaijk P, de Graaf TW, van der Zeijst BA, Boog CJ. Rots NY, et al. Among authors: boog cj. Vaccine. 2010 Jan 22;28(4):893-900. doi: 10.1016/j.vaccine.2009.10.125. Epub 2009 Nov 20. Vaccine. 2010. PMID: 19932217 Review.

5

Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

Stenger RM, Smits M, Kuipers B, van Gaans-van den Brink J, Poelen M, Boog CJ, van Els CA. Stenger RM, et al. Among authors: boog cj. Vaccine. 2010 Sep 14;28(40):6637-46. doi: 10.1016/j.vaccine.2010.06.118. Epub 2010 Jul 15. Vaccine. 2010. PMID: 20637762

6

Impaired production of TNF-α by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza.

Liu WM, Nahar TE, Jacobi RH, Gijzen K, van Beek J, Hak E, Jonges M, Boog CJ, van der Zeijst BA, Soethout EC. Liu WM, et al. Among authors: boog cj. Vaccine. 2012 Feb 21;30(9):1659-66. doi: 10.1016/j.vaccine.2011.12.105. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22230585

7

Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.

Zariri A, van Dijken H, Hamstra HJ, van der Flier M, Vidarsson G, van Putten JP, Boog CJ, van den Dobbelsteen G, van der Ley P. Zariri A, et al. Vaccine. 2013 Nov 12;31(47):5585-93. doi: 10.1016/j.vaccine.2013.07.069. Epub 2013 Aug 6. Vaccine. 2013. PMID: 23933369

8

Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation.

Brummelman J, Helm K, Hamstra HJ, van der Ley P, Boog CJ, Han WG, van Els CA. Brummelman J, et al. Among authors: boog cj. Vaccine. 2015 Mar 17;33(12):1483-91. doi: 10.1016/j.vaccine.2015.01.063. Epub 2015 Feb 7. Vaccine. 2015. PMID: 25659267

9

Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.

Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY. Soonawala D, et al. Vaccine. 2013 Aug 12;31(36):3688-94. doi: 10.1016/j.vaccine.2013.05.104. Epub 2013 Jun 13. Vaccine. 2013. PMID: 23770332 Clinical Trial.

10

Aging and impaired immunity to influenza viruses: implications for vaccine development.

Liu WM, van der Zeijst BA, Boog CJ, Soethout EC. Liu WM, et al. Among authors: boog cj. Hum Vaccin. 2011 Jan-Feb;7 Suppl:94-8. doi: 10.4161/hv.7.0.14568. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21301210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters